How big is Lineage Cell Therapeutics, Inc.?

Jun 22 2025 05:38 PM IST
share
Share Via
As of Jun 18, Lineage Cell Therapeutics, Inc. has a market capitalization of 196.02 million, with net sales of 9.56 million and a net profit of -16.16 million over the latest four quarters. The company reported shareholder's funds of 78.38 million and total assets of 113.22 million as of Dec 24.
Market Cap: As of Jun 18, Lineage Cell Therapeutics, Inc. has a market capitalization of 196.02 million, categorizing it as a Micro Cap company.

Recent Quarterly Performance: For the latest four quarters, Lineage Cell Therapeutics reported net sales of 9.56 million and a net profit of -16.16 million.

Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 78.38 million and total assets of 113.22 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Lineage Cell Therapeutics Hits New 52-Week High of $2.09
Nov 04 2025 05:45 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.95
Nov 03 2025 05:00 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.87
Oct 31 2025 04:00 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.85
Oct 15 2025 04:44 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.82
Oct 09 2025 07:58 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.72
Sep 29 2025 02:14 PM IST
share
Share Via
Lineage Cell Therapeutics Hits New 52-Week High of $1.64
Sep 24 2025 01:13 PM IST
share
Share Via